We read with great interest the article by Grika, et al, a retrospective analysis of the morbidity,
mortality, and organ damage in patients with antiphospholipid syndrome (APS), with or …

… thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing
the EULAR recommendations for the management of antiphospholipid syndrome in adults. …

… The antiphospholipid syndrome (APS) is diagnosed in patients with recurrent … evidence for
antiphospholipid antibodies. Diagnostic tests for the detection of antiphospholipid antibodies …

… The possibility of antiprothrombin antibodies, particularly aPS/PT, being an additional
tool for risk stratification is being actively debated, especially when trying to improve the …

… It can be a promising tool in the future for prediction of thrombosis. Anticoagulation remains
the … studies with the ultimate goal of providing the optimal management to patients with APS. …

Antiphospholipid syndrome (APS) is a rare disease characterised by venous and/or arterial …
the presence of specific autoantibodies called antiphospholipid antibodies. This review aims …

… The optimal intensity of anticoagulation following arterial thrombosis remains controversial.
… Score (aGAPSS) is a validated tool, including both aPL and conventional cardiovascular risk …

… Anti-β2GPI-DI antibodies may represent a promising tool when assessing thrombotic risk in
… data are need to establish indications and optimal doses of IVIG in thrombotic APS patients. …

… Antiphospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy
complications in the presence of persistent antiphospholipid antibodies (APLA). Laboratory …

… prophylaxis and its optimal intensity are challenging because of the lack of stratification tools
for the risk of thrombosis. Finally, decision on the optimal type of anticoagulant drug is also …